Compare CTSO & CVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | CVV |
|---|---|---|
| Founded | 1997 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 23.2M |
| IPO Year | 2008 | 2007 |
| Metric | CTSO | CVV |
|---|---|---|
| Price | $0.41 | $7.20 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.38 | N/A |
| AVG Volume (30 Days) | ★ 204.4K | 104.7K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.79 | 17.86 |
| EPS | ★ N/A | N/A |
| Revenue | $22,503,908.00 | ★ $41,128,639.00 |
| Revenue This Year | $10.34 | N/A |
| Revenue Next Year | $22.41 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 48.53 | ★ 96.27 |
| 52 Week Low | $0.37 | $2.76 |
| 52 Week High | $1.23 | $8.46 |
| Indicator | CTSO | CVV |
|---|---|---|
| Relative Strength Index (RSI) | 41.14 | 53.78 |
| Support Level | $0.37 | $3.14 |
| Resistance Level | $0.73 | $8.46 |
| Average True Range (ATR) | 0.05 | 0.59 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 18.10 | 54.26 |
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
CVD Equipment Corp is engaged in the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used to produce semiconductors and other electronic components. The company operates through the segments of CVD Equipment, CVD materials, and Stainless Design Concepts, MesoScribe. It generates maximum revenue from the CVD Equipment segment. The CVD Equipment segment manufactures and sells chemical vapor deposition, physical vapor transport, and similar equipment. Company operates in USA, North America, Europe, Middle East and Africa, and Asia-Pacific.